We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Sign up to read this article for FREE!

After signing up, you'll start to receive regular news updates from us.

Gentel® Obtains License from Agnitio for Protein Microarray Technology

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Gentel® Biosciences has announced that it has obtained an exclusive license to novel technology for manufacturing highly-reproducible nitrocellulose protein microarray slides.

The technology, developed by Agnitio Science and Technology of Hsinchu, Taiwan, covers the use of ultrasonic coating to produce nitrocellulose films. “Ultrasonic coating produces nitrocellulose films with a consistency unattainable using traditional coating processes like casting,” stated Dr. Bryce Nelson, Gentel’s VP of Research and Development. “Additionally, the technology is extremely flexible and can be used to fabricate optically clear or porous white nitrocellulose films.”

Gentel plans to incorporate ultrasonic coating technology into its manufacturing process for standard microarray slides as well as for its recently developed 96-well microarray platform, APiX 96™.

“The technology is highly scalable and will enable us to manufacture the number and type of protein microarray slides required for protein biomarker discovery, validation, and diagnostics,” says G. Randall Durnell, Gentel VP of Commercial Operations. “The acquisition of this intellectual property further extends Gentel’s position as the market leading protein microarray company.”

The ultrasonic coating technology is covered by a suite of issued and pending US and international patents.